Related Experiment Video
Updated: Jun 28, 2026

10:54
Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry
Published on: February 4, 2017
99m-Technetium carbohydrate conjugates as potential agents in molecular imaging
1Medicinal Inorganic Chemistry Group, Department of Chemistry, University of British Columbia, 2036 Main Mall, Vancouver, BC, CanadaV6T 1Z1.
Summary
Researchers are developing technetium-99m (99mTc) carbohydrate agents for SPECT imaging of cancer. This work focuses on novel glycoconjugates and their coordination chemistry for improved molecular imaging applications.
Area of Science:
- Radiochemistry
- Molecular Imaging
- Carbohydrate Chemistry
Background:
- Technetium-99m (99mTc) is a crucial radionuclide for diagnostic imaging.
- Carbohydrates play vital roles in biological processes and can be functionalized for targeted delivery.
- Molecular imaging aims to visualize and quantify biological processes at the molecular level.
Purpose of the Study:
- To review recent advancements in (99m)Tc-carbohydrate based agents for SPECT imaging.
- To explore the biological functions and coordination chemistry of carbohydrates in the context of molecular imaging.
- To discuss the development and application of novel (99m)Tc glycoconjugates, particularly those utilizing the (99m)Tc(v) and [(99m)Tc(I)(CO)(3)](+) cores.
Main Methods:
- Literature review of recent reports on (99m)Tc-carbohydrate agents.
- Discussion of carbohydrate biology, coordination chemistry, and bioconjugation techniques.
- Detailed examination of ligand sets designed for (99m)Tc(v) and [(99m)Tc(I)(CO)(3)](+) cores.
Main Results:
- Recent work has focused on developing (99m)Tc-carbohydrate agents for SPECT imaging, especially for cancerous tissues.
- The [(99m)Tc(I)(CO)(3)](+) core has emerged as a highly attractive platform for developing new imaging agents.
- Significant progress has been made in designing specific ligand sets for these (99m)Tc cores.
Conclusions:
- Technetium-99m carbohydrate-based agents show promise for targeted SPECT imaging of cancer.
- The coordination chemistry of technetium, particularly with bioconjugates like glycoconjugates, is key to developing effective imaging probes.
- Continued research into novel ligand design for cores like [(99m)Tc(I)(CO)(3)](+) will advance molecular imaging capabilities.
Related Concept Videos
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
Positron Emission Tomography
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...

